Point72 Asset Management Exits Position in Edesa Biotech, Inc. (EDSA)

Point72 Asset Management, L.P., along with Point72 Capital Advisors, Inc. and Steven A. Cohen, filed a Schedule 13G/A on May 15, 2026, regarding their holdings in Edesa Biotech, Inc. (EDSA). The filing indicates that as of March 31, 2026, the reporting persons have effectively exited their position in the company, reporting beneficial ownership of only 2 shares, which represents 0% of the outstanding common shares. This is an amendment to a previous filing and confirms that the reporting persons no longer hold a significant stake in Edesa Biotech. The shares were held by an investment fund managed by Point72 Asset Management, with Cubist Systematic Strategies, LLC acting as a sub-advisor for a portion of the shares. The reporting persons have certified that the securities were not held for the purpose of changing or influencing the control of the issuer.